Third Arc Bio
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
$52MSeries A+
Role not disclosedActivity from announced rounds
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
Pitching AbbVie Ventures? Send the deck from a free RoundOS data room and see which pages they read.